Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan
· Delayed Price · Currency is TWD 117.00
+1.50 (1.30%)
Apr 24, 2025, 1:30 PM CST
Alar Pharmaceuticals Revenue
In the year 2024, Alar Pharmaceuticals had annual revenue of 5.82M TWD, down -98.76%.
Revenue
5.82M
Revenue Growth
-98.76%
P/S Ratio
1,343.58
Revenue / Employee
215.44K
Employees
27
Market Cap
7.82B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Pegavision | 6.82B |
| Lumosa Therapeutics | 39.15M |